Pharmaceutical companies are outsourcing different operations related to manufacturing to contract manufacturers. This allows them to cut down on the costs of setting up new facilities and conducting drug development activities, thereby improving the net cash flow. The contract manufacturing organizations (CMOs) are investing on the development of in-house capabilities to secure significant market share in outsource
View More